PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1
International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel
- Status
- UNKNOWN
- Phase
- PHASE2
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adjuvant Chemotherapy for Locally Advanced Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
- Status
- TERMINATED
- Phase
- PHASE4
A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2